POSSIBILITIES OF RECOMBINANT INTERFERON Α-2B DRUGS IN THE COMPLEX THERAPY OF MUCOSAL CANDIDIASIS INFECTION IN PATIENTS AT RISK ArticleZlobin D.E., Gureeva M.A., Molochkov A.V., Misnikova I.V., Polesko I.V., Guseva T.S.Русский медицинский журнал. Медицинское обозрение. Vol. 8. 2024. P.. 433-438
EFFECTIVENESS OF RECOMBINANT INTERFERON ALPHA IN PREVENTION OF CANDIDA INFECTION IN PATIENTS AT RISK ArticleЗлобин Д.Э., Гуреева М.А., Молочков А.В., Мисникова И.В., Якубовская Е.С., Полеско И.В., Молочков В.А., Гусева Т.С.Klinicheskaya Dermatologiya i Venerologiya. Vol. 23. 2024. P.. 405-414
UNDERSTANDING AND ADDRESSING MUCOSAL CANDIDIASIS: THE INTERPLAY OF GLUCOSE CONTROL AND INTERFERON THERAPY ArticleZlobin Dmitry, Molochkov Anton, Misnikova Inna, Rusanova Elena, Bragina GalinaOtorhinolaryngology, Head and Neck Pathology. Vol. 2. 2023. P.. 13-14